PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122C00082THIS acquisition WILL ALLOW BARDA to — Aktivax Inc

Aktivax Inc holds — across 1 federal awards. Competition previously drew 2 offers. Set-aside status: NONE. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Aktivax Inc

Recipient

Dec 31, 2026

PoP end

$45.3M

Obligated

541714

NAICS

AN12

PSC

NONE

Set-aside

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Aktivax Inc — $90

Contract facts

NONE

Contract number75A50122C00082

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentAktivax Inc

UEIT1XHPCDJ4NT6

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12

Place of performanceBROOMFIELD, CO

Related solicitation75A50122R00022

PoP end (current)Dec 31, 2026

PoP end (w/ options)Dec 31, 2039

Obligated$45.3M

THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APP… is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Aktivax Inc. Estimated value $45.3M ($45.3M obligated). Current period of performance ends Dec 31, 2026 (potential Dec 31, 2039). Last award drew 2 bidders. Place of performance: BROOMFIELD, CO. Related solicitation 75A50122R00022.

THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT

Recompete timing

Public

● Expiring in 116 days

Current PoP ends Dec 31, 2026 (116 days remaining). Agencies typically plan 12–18 months ahead — at 3.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Aktivax Inc — — obligated across 1 awards (firm-wide, all agencies).

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50122C00082?

75A50122C00082 (THIS acquisition WILL ALLOW BARDA to) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $45.3M, currently held by Aktivax Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50122C00082?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50122C00082 to Aktivax Inc.

Who is the incumbent on 75A50122C00082?

Aktivax Inc is the incumbent with — across 1 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Aktivax Inc’s 75A50122C00082 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50122C00082 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Sep 11, 2024